US Stock MarketDetailed Quotes

CNTA Centessa Pharmaceuticals

Watchlist
  • 17.040
  • -1.150-6.32%
Close Nov 22 16:00 ET
  • 17.980
  • +0.940+5.52%
Post 20:01 ET
2.25BMarket Cap-11210P/E (TTM)

Centessa Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Centessa Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Centessa Pharmaceuticals Earnings Reports

  • Centessa Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

    Nov 12 09:31 ET

  • Centessa Pharmaceuticals | 8-K: Centessa Pharmaceuticals Reports Financial Results for the Third Quarter of 2024 and Provides Business Update

    Nov 12 09:30 ET

  • Centessa Pharmaceuticals | 10-Q/A: Quarterly report (Amendment)

    Oct 18 16:04 ET

  • Centessa Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 13 07:32 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 20, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data